KROS
Keros Therapeutics Inc

1,232
Mkt Cap
$505.13M
Volume
167,955.00
52W High
$22.55
52W Low
$9.12
PE Ratio
10.75
KROS Fundamentals
Price
$16.52
Prev Close
$16.58
Open
$16.65
50D MA
$19.33
Beta
0.90
Avg. Volume
355,487.40
EPS (Annual)
-$5.00
P/B
0.96
Rev/Employee
$21,005.92
$51.57
Loading...
Loading...

About

Keros Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with unmet medical need. The company was founded in 2015 and is headquartered in Lexington, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
169

Frequently Asked Questions

What is Market Cap of Keros Therapeutics Inc?
What is the 52-week high for Keros Therapeutics Inc?
What is the 52-week low for Keros Therapeutics Inc?
What is Keros Therapeutics Inc stock price today?
What was Keros Therapeutics Inc stock price yesterday?
What is the PE ratio of Keros Therapeutics Inc?
What is the Price-to-Book ratio of Keros Therapeutics Inc?
What is the 50-day moving average of Keros Therapeutics Inc?
How many employees does Keros Therapeutics Inc have?

Latest KROS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.